Spexin Enhances Bowel Movement through Activating L-type Voltage-dependent Calcium Channel via Galanin Receptor 2 in Mice

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Lin, Cheng Yuan ^a,b   Zhang, Man ^a,c   Huang, Tao ^a   Yang, Li Ling ^a   Fu, Hai Bo ^a   Zhao, Ling ^a   Zhong, Linda Ld ^a   Mu, Huai Xue ^a   Shi, Xiao Ke ^a   Leung, Christina Fp ^a   Fan, Bao Min ^a,b   Jiang, Miao ^d   Lu, Ai Ping ^a   Zhu, Li Xin ^e   Bian, Zhao Xiang ^a,b  

^a HONG KONG BAPTIST UNIVERSITY   (Hong Kong)

^b YUNNAN MINZU UNIVERSITY   (China)

^c GUANGZHOU MEDICAL UNIVERSITY   (China)

^d INSTITUTE OF CHINESE MATERIA MEDICA   (China)

^e UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1-PHENYL-3-((3-(TRIFLUOROMETHYL)PHENYL)IMINO)-1H-INDOL-2-ONE; C12ORF39 PROTEIN, HUMAN; CALCIUM; CALCIUM CHANNEL L TYPE; GALANIN RECEPTOR 2; GALANIN RECEPTOR 3; INDOLE DERIVATIVE; M871 PEPTIDE; NEUROPEPTIDE; NIFEDIPINE; PEPTIDE; PEPTIDE HORMONE;

ANIMAL; ANTAGONISTS AND INHIBITORS; C57BL MOUSE; CASE CONTROL STUDY; COLON; CONSTIPATION; DRUG EFFECTS; FEMALE; GASTROINTESTINAL TRANSIT; HUMAN; MALE; METABOLISM; MIDDLE AGED; MOUSE; MUSCLE CONTRACTION; PHYSIOLOGY; SMOOTH MUSCLE CELL;

ANIMALS; CALCIUM; CALCIUM CHANNELS, L-TYPE; CASE-CONTROL STUDIES; COLON; CONSTIPATION; FEMALE; GASTROINTESTINAL TRANSIT; HUMANS; INDOLES; MALE; MICE; MICE, INBRED C57BL; MIDDLE AGED; MUSCLE CONTRACTION; MYOCYTES, SMOOTH MUSCLE; NEUROPEPTIDES; NIFEDIPINE; PEPTIDE HORMONES; PEPTIDES; RECEPTOR, GALANIN, TYPE 2; RECEPTOR, GALANIN, TYPE 3;

EID: 84937019832     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep12095     Document Type: Article

References (45)

1. Mirabeau, O. et al. Identification of novel peptide hormones in the human proteome by hidden Markov model screening. Genome research 17, 320-327 doi: 10.1101/gr.5755407 (2007).
2. Sonmez, K. et al. Evolutionary sequence modeling for discovery of peptide hormones. PLoS computational biology 5, e1000258 doi: 10.1371/journal.pcbi.1000258 (2009).
3. Wong, M. K. H. et al. Goldfish spexin: solution structure and novel function as a satiety factor in feeding control. Am J Physiol-Endoc M 305, E348-E366 doi: 10.1152/ajpendo.00141.2013 (2013).
4. Porzionato, A. et al. Spexin Expression in Normal Rat Tissues. J Histochem Cytochem 58, 825-837 doi: 10.1369/jhc.2010.956300 (2010).
5. Toll, L. et al. Peptides derived from the prohormone proNPQ/spexin are potent central modulators of cardiovascular and renal function and nociception. Faseb J 26, 947-954 doi: 10.1096/Fj.11-192831 (2012).
6. Liu, Y. et al. A novel neuropeptide in suppressing luteinizing hormone release in goldfish, Carassius auratus. Mol Cell Endocrinol 374, 65-72 doi: 10.1016/j.mce.2013.04.008 (2013).
7. Walewski, J. L. et al. Spexin is a novel human peptide that reduces adipocyte uptake of long chain fatty acids and causes weight loss in rodents with diet-induced obesity. Obesity (Silver Spring) 22, 1643-1652 doi: 10.1002/oby.20725 (2014).
8. von Rosenvinge, E. C. & Raufman, J. P. Gastrointestinal peptides and regulation of gastric acid secretion. Current opinion in endocrinology, diabetes, and obesity 17, 40-43 doi: 10.1097/MED.0b013e32833304e1 (2010).
9. Chen, C. Y. & Tsai, C. Y. Ghrelin and motilin in the gastrointestinal system. Current pharmaceutical design 18, 4755-4765 (2012).
10. Rehfeld, J. F. Beginnings: a reflection on the history of gastrointestinal endocrinology. Regulatory peptides 177 Suppl, S1-5 doi: 10.1016/j.regpep.2012.05.087 (2012).
11. Anselmi, L. et al. Galanin receptors in the rat gastrointestinal tract. Neuropeptides 39, 349-352 (2005).
12. Arciszewski, M. B., Barabasz, S. & Calka, J. Immunohistochemical localization of galanin receptors (GAL-R1, GAL-R2, and GAL-R3) on myenteric neurons from the sheep and dog stomach. Annals of anatomy = Anatomischer Anzeiger : official organ of the Anatomische Gesellschaft 190, 360-367 doi: 10.1016/j.aanat.2008.04.004 (2008).
13. Kim, D. K. et al. Coevolution of the spexin/galanin/kisspeptin family: Spexin activates galanin receptor type II and III. Endocrinology 155, 1864-1873 doi: 10.1210/en.2013-2106 (2014).
14. Mazarati, A. et al. Galanin type 2 receptors regulate neuronal survival, susceptibility to seizures and seizure-induced neurogenesis in the dentate gyrus. The European journal of neuroscience 19, 3235-3244 doi: 10.1111/j.0953-816X.2004.03449.x (2004).
15. Badie-Mahdavi, H., Lu, X., Behrens, M. M. & Bartfai, T. Role of galanin receptor 1 and galanin receptor 2 activation in synaptic plasticity associated with 3′,5′-cyclic AMP response element-binding protein phosphorylation in the dentate gyrus: studies with a galanin receptor 2 agonist and galanin receptor 1 knockout mice. Neuroscience 133, 591-604 doi: 10.1016/j.neuroscience.2005.02.042 (2005).
16. Swanson, C. J. et al. Anxiolytic- and antidepressant-like profiles of the galanin-3 receptor (Gal3) antagonists SNAP 37889 and SNAP 398299. Proceedings of the National Academy of Sciences of the United States of America 102, 17489-17494 doi: 10.1073/pnas.0508970102 (2005).
17. Bailey, K. R., Pavlova, M. N., Rohde, A. D., Hohmann, J. G. & Crawley, J. N. Galanin receptor subtype 2 (GalR2) null mutant mice display an anxiogenic-like phenotype specific to the elevated plus-maze. Pharmacology, biochemistry, and behavior 86, 8-20 doi: 10.1016/j.pbb.2006.11.024 (2007).
18. Wang, S. et al. The GalR2 galanin receptor mediates galanin-induced jejunal contraction, but not feeding behavior, in the rat: differentiation of central and peripheral effects of receptor subtype activation. FEBS letters 434, 277-282 (1998).
19. Kotal, P., Vitek, L. & Fevery, J. Fasting-related hyperbilirubinemia in rats: the effect of decreased intestinal motility. Gastroenterology 111, 217-223 (1996).
20. Pucciani, F., Ringressi, M. N., Maltinti, G. & Bechi, P. Transverse loop colostomy and colonic motility. Techniques in coloproctology 18, 1029-1034 doi: 10.1007/s10151-014-1173-5 (2014).
21. Mirotznik, R. R., Zheng, X. & Stanley, E. F. G-Protein types involved in calcium channel inhibition at a presynaptic nerve terminal. The Journal of neuroscience : the official journal of the Society for Neuroscience 20, 7614-7621 (2000).
22. Weiss, S. et al. Modulation of distinct isoforms of L-type calcium channels by G(q)-coupled receptors in Xenopus oocytes: antagonistic effects of Gbetagamma and protein kinase C. Channels 6, 426-437 doi: 10.4161/chan.22016 (2012).
23. Bolton, T. B., Prestwich, S. A., Zholos, A. V. & Gordienko, D. V. Excitation-contraction coupling in gastrointestinal and other smooth muscles. Annu Rev Physiol 61, 85-115 doi: 10.1146/annurev.physiol.61.1.85 (1999).
24. Wang, S., Hashemi, T., Fried, S., Clemmons, A. L. & Hawes, B. E. Differential intracellular signaling of the GalR1 and GalR2 galanin receptor subtypes. Biochemistry 37, 6711-6717 doi: 10.1021/bi9728405 (1998).
25. Branchek, T. A., Smith, K. E., Gerald, C. & Walker, M. W. Galanin receptor subtypes. Trends in pharmacological sciences 21, 109-117 (2000).
26. Smith, K. E. et al. Cloned human and rat galanin GALR3 receptors. Pharmacology and activation of G-protein inwardly rectifying K+ channels. The Journal of biological chemistry 273, 23321-23326 (1998).
27. Anselmi, L. et al. Galanin receptors in the rat gastrointestinal tract. Neuropeptides 39, 349-352 doi: 10.1016/j.npep.2004.12.023 (2005).
28. Fang, P. et al. Galanin and its receptors: a novel strategy for appetite control and obesity therapy. Peptides 36, 331-339 doi: 10.1016/j.peptides.2012.05.016 (2012).
29. Li, R. Y. et al. Galanin inhibits leptin expression and secretion in rat adipose tissue and 3T3-L1 adipocytes. J Mol Endocrinol 33, 11-19 doi: 10.1677/jme.0.0330011 (2004).
30. Joibari, M. M. & Khazali, H. Effect of Stress on Fasting-Induced Ghrelin, Orexin and Galanin Secretion in Male Rats Fed Different Levels of Their Energy Requirement. Obesity 21, 130-134 doi: 10.1038/Oby.2012.185 (2013).
31. Pan, N. C., Bai, Y. F., Yang, Y., Hokfelt, T. & Xu, Z. Q. Activation of galanin receptor 2 stimulates large conductance Ca(2+)-dependent K(+) (BK) channels through the IP3 pathway in human embryonic kidney (HEK293) cells. Biochemical and biophysical research communications 446, 316-321 doi: 10.1016/j.bbrc.2014.02.110 (2014).
32. Niiro, N., Nishimura, J., Hirano, K., Nakano, H. & Kanaide, H. Mechanisms of galanin-induced contraction in the rat myometrium. Br J Pharmacol 124, 1623-1632 doi: 10.1038/sj.bjp.0702004 (1998).
33. Sanders, K. M., Koh, S. D., Ro, S. & Ward, S. M. Regulation of gastrointestinal motility-insights from smooth muscle biology. Nature reviews. Gastroenterology & hepatology 9, 633-645 doi: 10.1038/nrgastro.2012.168 (2012).
34. Fung, C., Unterweger, P., Parry, L. J., Bornstein, J. C. & Foong, J. P. VPAC1 receptors regulate intestinal secretion and muscle contractility by activating cholinergic neurons in guinea pig jejunum. American journal of physiology. Gastrointestinal and liver physiology 306, G748-758 doi: 10.1152/ajpgi.00416.2013 (2014).
35. Zhong, L. L. et al. Chinese herbal medicine (Ma Zi Ren Wan) for functional constipation: study protocol for a prospective, double-blinded, double-dummy, randomized controlled trial. Trials 14, 366 doi: 10.1186/1745-6215-14-366 (2013).
36. Drossman, D. A. & Dumitrascu, D. L. Rome III: New standard for functional gastrointestinal disorders. Journal of gastrointestinal and liver diseases: JGLD 15, 237-241 (2006).
37. Lembo, A. J. et al. Efficacy of linaclotide for patients with chronic constipation. Gastroenterology 138, 886-895 e881, doi: 10.1053/j.gastro.2009.12.050 (2010).
38. Johnston, J. M. et al. Pilot study on the effect of linaclotide in patients with chronic constipation. The American journal of gastroenterology 104, 125-132 doi: 10.1038/ajg.2008.59 (2009).
39. Zhou, Y. et al. Enteric nervous system abnormalities are present in human necrotizing enterocolitis: potential neurotransplantation therapy. Stem cell research & therapy 4, 157 doi: 10.1186/scrt387 (2013).
40. Fichna, J. et al. Salvinorin A inhibits colonic transit and neurogenic ion transport in mice by activating kappa-opioid and cannabinoid receptors. Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society 21, 1326-e1128 doi: 10.1111/j.1365-2982.2009.01369.x (2009).
41. Bian, Z. X. et al. Inhibitory effects of magnolol on distal colon of guinea pig in vitro. Biological & pharmaceutical bulletin 29, 790-795 (2006).
42. Bossone, C., Hosseini, J. M., Pineiro-Carrero, V. & Shea-Donohue, T. Alterations in spontaneous contractions in vitro after repeated inflammation of rat distal colon. American journal of physiology. Gastrointestinal and liver physiology 280, G949-957 (2001).
43. Zhang, M., Leung, F. P., Huang, Y. & Bian, Z. X. Increased colonic motility in a rat model of irritable bowel syndrome is associated with up-regulation of L-type calcium channels in colonic smooth muscle cells. Neurogastroent Motil 22, e162-e170 doi: 10.1111/j.1365-2982.2009.01467.x (2010).
44. Kinoshita, K., Sato, K., Hori, M., Ozaki, H. & Karaki, H. Decrease in activity of smooth muscle L-type Ca2+ channels and its reversal by NF-kappaB inhibitors in Crohn's colitis model. American journal of physiology. Gastrointestinal and liver physiology 285, G483-493 doi: 10.1152/ajpgi.00038.2003 (2003).
45. Sun, C. et al. UII and UT in grouper: cloning and effects on the transcription of hormones related to growth control. The Journal of endocrinology 220, 35-48 doi: 10.1530/JOE-13-0282 (2014).